首页> 美国卫生研究院文献>Antibodies >IgA: Structure Function and Developability
【2h】

IgA: Structure Function and Developability

机译:IgA:结构功能和可开发性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Immunoglobulin A (IgA) plays a key role in defending mucosal surfaces against attack by infectious microorganisms. Such sites present a major site of susceptibility due to their vast surface area and their constant exposure to ingested and inhaled material. The importance of IgA to effective immune defence is signalled by the fact that more IgA is produced than all the other immunoglobulin classes combined. Indeed, IgA is not just the most prevalent antibody class at mucosal sites, but is also present at significant concentrations in serum. The unique structural features of the IgA heavy chain allow IgA to polymerise, resulting in mainly dimeric forms, along with some higher polymers, in secretions. Both serum IgA, which is principally monomeric, and secretory forms of IgA are capable of neutralising and removing pathogens through a range of mechanisms, including triggering the IgA Fc receptor known as FcαRI or CD89 on phagocytes. The effectiveness of these elimination processes is highlighted by the fact that various pathogens have evolved mechanisms to thwart such IgA-mediated clearance. As the structure–function relationships governing the varied capabilities of this immunoglobulin class come into increasingly clear focus, and means to circumvent any inherent limitations are developed, IgA-based monoclonal antibodies are set to emerge as new and potent options in the therapeutic arena.
机译:免疫球蛋白A(IgA)在防御粘膜表面免受传染性微生物侵袭中起关键作用。由于这些部位的表面积很大,并且经常与摄入和吸入的物质接触,因此这些部位是主要的易感部位。 IgA产生的IgA比所有其他免疫球蛋白类别的总和还多,这一事实表明了IgA对有效免疫防御的重要性。实际上,IgA不仅是粘膜部位最普遍的抗体类别,而且还以显着浓度存在于血清中。 IgA重链的独特结构特征允许IgA聚合,导致分泌物中主要是二聚体形式以及一些高级聚合物。血清IgA(主要是单体的)和分泌形式的IgA均能够通过一系列机制中和和去除病原体,包括触发吞噬细胞上的称为FcαRI或CD89的IgA Fc受体。这些病原体已经进化出阻止此类IgA介导清除的机制,这一事实突显了这些消除过程的有效性。随着控制这种免疫球蛋白类别各种功能的结构与功能关系日益成为人们关注的焦点,并且开发了规避任何固有局限性的方法,基于IgA的单克隆抗体有望在治疗领域崭露头角。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号